F-18 FDG positron emission tomography demonstrates resolution of non-Hodgkin's lymphoma of the parotid gland in a patient with Sjogren's syndrome: before and after anti-CD20 antibody rituximab therapy.
Shih
Wei-Jen
WJ
Nuclear Medicine Service, Lexington VA Medical Center, the University of Kentucky Medical Center, 40511, USA. wshih0@pop.uky.edu
Ghesani
Nasrin
N
Hongming
Zhuang
Z
Alavi
Abass
A
Schusper
Steven
S
Mozley
Davis
D
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D019788:Fluorodeoxyglucose F18; D006801:Humans; D016393:Lymphoma, B-Cell / Q000150:complications / Q000000981:diagnostic imaging / Q000628:therapy; D008228:Lymphoma, Non-Hodgkin / Q000150:complications / Q000000981:diagnostic imaging* / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010307:Parotid Neoplasms / Q000000981:diagnostic imaging* / Q000628:therapy*; D019275:Radiopharmaceuticals; D000069283:Rituximab; D012859:Sjogren's Syndrome / Q000150:complications*; D014055:Tomography, Emission-Computed
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D000069283:Rituximab